We're not in a good position to say it doesn't have the potential
In the wake of three deaths aboard the MV Hondius cruise ship, a rare Andes hantavirus outbreak has quietly illuminated the cost of a decision made far from any hospital ward. The virus, unusual among its kind for its capacity to pass between people, traveled undetected through Antarctic waters and across international borders before health authorities could respond — a journey made more troubling by the 2025 cancellation of US-funded research designed to understand exactly this pathogen. As contact tracers work across multiple countries and scientists speak carefully about what might have been known, the outbreak asks an old and uncomfortable question: what is the price of forgetting a danger before it reminds us it exists?
- Three passengers are dead and five confirmed infections have been traced to a luxury cruise ship that unknowingly carried Andes hantavirus through some of the world's most remote waters.
- Because the virus incubates for up to six weeks and passengers had already dispersed internationally before illness was detected, health authorities are now racing to trace contacts across multiple countries with incomplete information.
- The Andes strain is uniquely dangerous among hantaviruses because it can — rarely, and through mechanisms still not fully understood — pass from person to person, raising fears that a confined shipboard environment may have accelerated exposure.
- A US-funded Argentine research programme studying exactly this virus's transmission was shut down in 2025 after federal funding cuts, leaving scientists without data that could have sharpened the current response.
- The WHO has moved to contain alarm, stressing the virus does not spread through populations the way Covid-19 did, but the outbreak has reignited a fierce debate about whether dismantling infectious disease research infrastructure creates dangers that outlast any budget saving.
Three people are dead after the MV Hondius, a luxury cruise ship that departed Argentina in April, carried Andes hantavirus through Antarctic waters and across the Atlantic before anyone aboard knew it was there. Five cases have now been confirmed, and with passengers already scattered across international borders by the time illness was detected, contact tracing has become a multinational effort conducted against the clock.
The Andes strain of hantavirus is rare and genuinely unusual. Where most hantaviruses spread only through contact with infected rodents, the Andes variant can — under circumstances scientists do not yet fully understand — pass between people. Transmission may occur through direct exposure to saliva, though whether aerosol droplets play a role remains unclear. What is not unclear is the severity of infection: fluid in the lungs, respiratory failure, hemorrhagic fever, kidney failure. An incubation period of one to six weeks means exposures are often invisible until it is too late to trace them cleanly.
The outbreak has collided with a decision made quietly in Washington a year earlier. The Trump administration eliminated federal funding for an Argentine research programme that was investigating precisely how hantavirus moves from rodents to humans and whether person-to-person transmission could occur more easily under certain conditions. The programme was part of a broader NIH-supported network. Scott Weaver, who helped lead the effort, acknowledged to Scientific American that the cancelled research would probably not have prevented this particular outbreak — but warned that defunding work on lesser-known pathogens leaves countries unprepared for what comes next.
The WHO has sought to steady public concern, with Director-General Tedros Adhanom Ghebreyesus making clear this is not the opening of another Covid-19 pandemic. The virus does not move through populations the way that one did. But with three people dead and health systems scrambling across continents, the argument researchers made in their final funding filing — that continued study would reduce response times and strengthen preparedness — now carries a weight it did not have when it was written.
Three people are dead. A luxury cruise ship that departed from Argentina in April carried an invisible threat through Antarctic waters and across the Atlantic before anyone knew it was there. The MV Hondius has now become the focal point of an international health emergency, with five confirmed cases of Andes hantavirus and contact tracing efforts spreading across multiple countries as passengers who left the vessel before illness was detected scatter back to their homes.
The outbreak has forced a reckoning with a decision made quietly in Washington. A year ago, the Trump administration eliminated federal funding for a research programme designed to study exactly this kind of threat—a pilot project based in Argentina that was investigating how hantavirus moves from rodents to humans and whether the virus could spread more easily between people under certain conditions. The programme was part of a larger network called the West African Center for Emerging Infectious Diseases, which had been supported by the National Institutes of Health. Scott Weaver, who led the effort, had helped Argentine researchers secure funding for their work. Now, as health authorities worldwide monitor the fallout from the cruise ship outbreak, scientists are asking what might have been learned if that research had continued.
The Andes strain of hantavirus is unusual in ways that make it genuinely worrying. Most hantaviruses spread only through contact with infected rodents—their urine, saliva, droppings. The Andes variant is different. It can pass from person to person, though experts emphasize this transmission remains rare and they still do not fully understand the mechanism. The virus may spread through direct exposure to saliva, possibly through kissing, though whether coughing or sneezing can transmit it through aerosol droplets remains unclear. What is clear is that infection can turn severe quickly: fluid accumulating in the lungs, breathing failure, hemorrhagic fever, kidney failure. The incubation period stretches from one to six weeks, which means health authorities often cannot identify exposures until it is too late.
The MV Hondius departed Argentina in April and travelled through remote regions—Antarctica, isolated Atlantic islands—before the outbreak was detected. By then, passengers had already dispersed across international borders. The World Health Organisation called the situation serious but stressed that the overall public health risk remains low because the virus does not spread easily among humans. WHO Director-General Tedros Adhanom Ghebreyesus made clear this is not the beginning of another Covid-19 pandemic. The virus simply does not move through populations the way that one did.
Yet the timing of the outbreak has reopened a debate that many hoped was settled. The cancelled Argentina research project would probably not have prevented this particular outbreak, Weaver acknowledged to Scientific American. But he warned that cutting funding for research into lesser-known viruses leaves countries unprepared for what might come next. The WAC-EID programme had already improved outbreak detection systems for diseases like dengue fever in West Africa. In their final filing before the cuts, researchers argued that continuing the work would reduce response times to emerging infectious disease threats and strengthen preparedness for future outbreaks. Now, with three people dead and international health systems scrambling to trace contacts across continents, that argument carries a different weight. The question is no longer theoretical: what happens when you stop studying the diseases that have not yet killed many people, but could?
Notable Quotes
We supported them to put in an application for a pilot award, and they were successful in getting funded. We found out that there was a group in Argentina that wanted to do similar kinds of things that we were doing in West Africa.— Scott Weaver, former principal investigator at West African Center for Emerging Infectious Diseases
We're not in a good position to say [hantavirus], just because it's never caused big outbreaks, doesn't have the potential to do that one day.— Scott Weaver
The Hearth Conversation Another angle on the story
Why does it matter that this particular research project was cancelled? Couldn't other labs study hantavirus?
The Argentina team was already embedded in the region where the virus circulates. They understood local rodent populations, transmission patterns, the specific conditions that might make human-to-human spread more likely. That institutional knowledge, once lost, takes years to rebuild.
The WHO says the public health risk is low. So why are scientists so concerned?
Because low risk is not the same as no risk. Andes hantavirus has never caused a large outbreak. That does not mean it cannot. We stopped studying it just as we were beginning to understand it better.
Could the research have prevented this outbreak?
Probably not this one. But it might have helped us detect it faster, understand transmission better, prepare hospitals in high-risk areas. Prevention and preparedness are different things.
Is this about politics, or is it about money?
It is about both. The cuts were ideological—a broad pullback from infectious disease surveillance. But the consequence is purely practical: fewer people asking the hard questions about rare viruses until those viruses remind us why we should have been.
What happens now?
We watch. We trace contacts. We hope the virus does not mutate in ways that make it spread more easily. And we wait to see whether this outbreak changes how governments fund research into diseases that have not yet become household names.